 |
Beneficial
Effects of Insulin on Glycemic Control and ß-Cell Function in Newly Diagnosed Type 2 Diabetes With Severe Hyperglycemia After
Short-Term Intensive Insulin Therapy |
| |
A 6-month course of insulin therapy, compared
with OAD treatment, could more effectively achieve adequate glycemic
control and significant improvement of ß-cell function in new-onset type 2 diabetic patients with severe hyperglycemia
(Diabetes Care) |
| |
|
 |
Timing
Is Everything: Age of Onset Influences Long-Term Retinopathy
Risk in Type 2 Diabetes, Independent of Traditional Risk Factors |
| |
These data suggest an increased inherent susceptibility
to diabetic retinopathy with earlier-onset type 2 diabetes. This
further supports the importance of delaying development of diabetes
and also implies a need for more stringent metabolic targets for
younger individuals (Diabetes Care) |
| |
|
 |
Effectiveness
of continuous glucose monitoring in pregnant women with diabetes:
randomised clinical trial |
| |
Continuous glucose monitoring during pregnancy
is associated with improved glycaemic control in the third trimester,
lower birth weight, and reduced risk of macrosomia (BMJ, UK) |
| |
|
 |
Liraglutide
improves glucose control, increases weight loss |
| |
Novo Nordisk has been boosted by the publication
of positive data from a late-stage trial comparing the Danish firm’s investigational diabetes drug liraglutide with Sanofi-Aventis’ Amaryl (PharmaTimes) |
| |
|
 |
Facing
today’s challenges in diabetes education |
| |
Access to care is one problem facing diabetes
education; solutions are out there, according to some educators
(Endocrine Today) |
| |
|
 |
Conceptual
Model of Symptom-Focused Diabetes Care for African Americans |
| |
The symptom-focused conceptual model is an innovative
approach to tailoring care to a distinct population and to engaging
participants in their own self-care (redOrbit, USA) |
| |
|
 |
The
genetics of type 2 diabetes: a realistic appraisal circa 2008 |
| |
While substantial progress in our knowledge
of the genetic basis of type 2 diabetes is taking place, these
new discoveries represent but a small proportion of the genetic
variation underlying the susceptibility to this disorder (Journal
of Clinical Endocrinology & Metabolism) |
| |
|